Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07253246
PHASE1

ENX-205 SAD/PET Study in Healthy Adults

Sponsor: Engrail Therapeutics INC

View on ClinicalTrials.gov

Summary

This is a two-part study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and receptor occupancy (RO) of ENX-205 in healthy adult participants in a double-blind placebo-controlled, single ascending dose (SAD) study (Part 1) and an open-label, single-dose, positron emission tomography (PET) study (Part 2).

Official title: A Two-Part, Single Ascending Dose and Positron Emission Tomography Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Receptor Occupancy After Single Oral Dose Administration of ENX-205 in Healthy Adult Participants

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-03-23

Completion Date

2026-04

Last Updated

2026-03-11

Healthy Volunteers

Yes

Interventions

DRUG

ENX-205

oral solution

DRUG

Placebo

oral solution

Locations (1)

Parexel London EPCU

London, Middlesex, United Kingdom